HealthTechMovers.com has identified several healthtech stocks which are expected to go “Ex-Dividend” very soon. Remember, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
PoliticsAndMyPortfolio.com is looking into these tickers DAWN, MTDR, AVY, CMC, MNST, RTX and more.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Abbott Labs
Symbol: ABT
Recent ABT Price: $113.85
Average Analyst Price Target: $119.85 (5.27%)
ABT Market Cap: $195.86B
Expected Ex-Dividend Date for ABT stock: Jan 12 2023
Expected Payment Date for ABT stock: Feb 15 2023
Expected Dividend & Yield for ABT stock: 1.67%
Recent Analyst Action: Cecilia Furlong, analyst at Morgan Stanley, reiterates coverage on Abbott Labs (ABT) stock in the Healthcare sector with a Buy rating and a price target of $ 133 (4 days ago).
Click for full story on ABT stock >>--------------------------------------------------------------------------
AbbVie
Symbol: ABBV
Recent ABBV Price: $159.64
Average Analyst Price Target: $159.29 (-0.22%)
ABBV Market Cap: $294.54B
Expected Ex-Dividend Date for ABBV stock: Jan 12 2023
Expected Payment Date for ABBV stock: Feb 15 2023
Expected Dividend & Yield for ABBV stock: 3.39%
Recent Analyst Action: Robyn Karnauskas, analyst at Truist Financial, reiterates coverage on AbbVie (ABBV) stock in the Healthcare sector with a Buy rating and a price target of $ 180 (5 days ago).
Click for full story on ABBV stock >>--------------------------------------------------------------------------
PoliticsAndMyPortfolio.com keeps our subscribers informed of breaking news, reports, stock news or information that can have a positive or negative impact on their portfolio. We look at world events, political activity and the movement of stocks, bonds, metals, commodities and more to provide investors with timely information. Join thousands of investors who already signed up for our free subscription to PoliticsAndMyPortfolio.com.
